Top Institutions in Ophthalmology - Retinal Diseases
Ranking is based on institutional leadership in retinal disease research, clinical trial involvement in GA and AMD, pioneering work in complement biology, and translational research in novel therapies including gene and cell-based treatments.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a global leader in retinal disease research, with extensive clinical trial programs in AMD and GA, and pioneering work in complement inhibition therapies. Their collaboration with Harvard Medical School enhances translational research and innovation in novel therapeutic approaches.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is internationally recognized for its clinical and research excellence in retinal diseases, including AMD and GA. It has a robust clinical trials infrastructure and has contributed significantly to understanding complement-mediated retinal degeneration.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a leader in retinal disease research with a strong emphasis on the molecular mechanisms of AMD and GA, including complement system dysregulation. Their translational research bridges basic science and clinical application.
-
#4
University of California, San Francisco (UCSF) Department of Ophthalmology
San Francisco, CA
UCSF has a strong clinical and research focus on AMD and GA, with active involvement in complement inhibition trials and novel therapeutic development including gene therapy and mitochondrial research.
-
#5
Moorfields Eye Hospital and UCL Institute of Ophthalmology
London, N/A
Moorfields Eye Hospital, in partnership with UCL, is a world-renowned center for retinal disease research and clinical trials, including pioneering work in complement biology and gene therapy for GA and AMD.